65 studies found for: Open Studies | "Epstein-Barr Virus Infections"
Genetic Studies of Chronic Active Epstein-Barr Disease
Mental Training for CFS Following EBV Infection in Adolescents
A Study of the Safety and Efficacy of EBV Specific T-cell Lines
ValGanciclovir Versus ValAcyclovir for Viral Prophylaxis in Kidney Transplantation
Using Multi-virus Cytotoxic T-cells Following T-Cell Depleted Allogeneic HPCT for Prophylaxis Against Epstein Barr Virus, Adenovirus, And Cytomegalovirus
Individualized Treatment in Treating Patients With Stage II-IVB Nasopharyngeal Cancer Based on EBV DNA
Transfusion-related EBV Infection Among Allogeneic Stem Cell Transplant Pediatric Recipients
Cytotoxic T Cells to Treat Relapsed EBV-positive Lymphoma
Burkitt Leukemia - Dose-Adjusted Etoposide, Prednisone, Vincristine, Cyclophosphamide, and Ofatumumab (EPOCH - O)
The Use of Point-of-Care Ultrasound in the Diagnosis of Acute Infectious Mononucleosis in the Emergency Department
High-Dose Y-90-Ibritumomab Tiuxetan Added to Reduced-Intensity Allogeneic Stem Cell Transplant Regimen for Relapsed or Refractory Aggressive B-Cell Lymphoma
|12||Not yet recruiting||
A Study of Blinatumomab in Patients With Pre B-cell ALL and B-cell NHL as Post-allo-HSCT Remission Maintenance
|13||Not yet recruiting||
Nivolumab With or Without Varlilumab in Treating Patients With Relapsed or Refractory Aggressive B-cell Lymphomas
Nivolumab and Lenalidomide in Treating Patients With Relapsed or Refractory Non-Hodgkin or Hodgkin Lymphoma
Evaluation of ProALL miRs in Blood Specimen for Prediction of ALL Relapse Risk
Haploidentical BMT With Post-Transplant Cyclophosphamide and Bendamustine
Obinutuzumab, Venetoclax, and Lenalidomide in Treating Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma
Pembrolizumab and Ibrutinib in Treating Patients With Relapsed or Refractory Non-Hodgkin Lymphoma
The Safety and Efficacy of CART-19 Cells in B-cell Acute Lymphoblastic Leukemia (B-ALL).
Identifying, Understanding, and Overcoming Barriers to the Use of Clinical Practice Guidelines in Pediatric Oncology
† Study has passed its completion date and status has not been verified in more than two years.